Clinical Characteristics and Treatment with Various Tyrosine Kinase Inhibitors in Patients with ETV6-ABL1 positive Eosinophilia-Associated Myeloproliferative Neoplasms
Year: 2016
Type: article
Source: Blood
Authors: Andreas Reiter, Gunay Ahmadova, Mohamad Jawhar, Andres Virchis, Tim Somervaille, Mark Williams, Bernd Schönberger, Rebecca Frewin, Philipp J. Jost, Annett Maschke, Peter Keller, Torsten Haferlach, Nicole Naumann, Juliana Schwaab, Alice Fabarius, Wolf-Karsten Hofmann, Claudia Haferlach, Nicholas C.P. Cross, Georgia Metzgeroth
Institutions: Heidelberg University, Medizinische Fakultät Mannheim, The Royal Free Hospital, University College London, The Christie NHS Foundation Trust, The Christie Hospital, Gloucestershire Royal Hospital, Technical University of Munich, Helios Hospital Berlin-Buch, University Hospital of Bern, Munich Leukemia Laboratory (Germany), Wessex Regional Genetics Laboratory, University of Southampton
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2603630770